D354TRG Protecta XT CRT-D
Cardiac Resynchronization Therapy - Defibrillation (CRT-Defib)
D354TRG Protecta XT CRT-D
Information

Device Survival Probability

D3xxTRx_SURV
Loading...










    1 yr 2 yr 3 yr at 40.0 mo            
% Excluding Normal Battery Depletion 100.0 99.9 99.8 99.8            
% Including Normal Battery Depletion 99.9 99.1 96.3 95.6            
#   54707 27693 3717 342            
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Advisories For This Model

  • There are no advisories for this model.

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type CRT-Defib
NBD Code DDE-DDDR
Max. Delivered Energy 35 J
More
Connector Style CRT-D Style
Serial Number Prefix PSF
Mass 68 g
Volume 38 cc
Waveform Biphasic
X-Ray ID PSI
Hide this content
CRT-D Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.2 3.8 4.4 4.7
Quarterly 4.4 5.5 6.8 7.5
Semi-annual 4.8 6.2 7.9 9.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Integrated bi-ventricular pacing RV+LV; Left Ventricle Impedance 510ohms; Left Ventricular Pulse Width 0.4ms; Left Ventricular Pulse Amplitude 3V; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

EOS Indication

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Distribution Data

US Market Release
CE Approval Date2010-03-25
Registered USA Implants1
Estimated Active USA Implants0
Normal Battery Depletions
US Market Release
CE Approval Date2010-03-25
Estimated WW Distribution831
Normal Battery Depletions85
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 17
Electrical Component 7
Possible Early Battery Depletion 10
Therapy Function Compromised 2
Electrical Component 2
Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.63V on 3 consecutive daily automatic measurments.

Information

Charge Time

D354TRx_CHRG
Loading...

Data as of August 3, 2014

www.medtronic.com/productperformance 326050